GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Incannex Healthcare
Incannex is an Australian biotech company developing cannabinoid- and psychedelic-based drugs. Its stock price is a venture capital bet that these substances will become legal and approved medications for the treatment of various diseases.
Share prices of companies in the market segment - Narco food
Incannex Healthcare is an Australian biopharmaceutical company developing cannabinoid- and psychedelic-based drugs for the treatment of various conditions. We've classified it as a "Narco-Food" stock. The chart below shows how investors view the medical marijuana and psychedelics sectors.
Broad Market Index - GURU.Markets
Incannex Healthcare is an Australian biopharmaceutical company developing cannabinoid- and psychedelic-based medications for the treatment of various conditions. It is a component of the GURU.Markets index. The chart below shows the US market. See how this company's stock compares to the US market.
Change in the price of a company, segment, and market as a whole per day
IXHL - Daily change in the company's share price Incannex Healthcare
For Incannex Healthcare Ltd, a company developing cannabinoid-based drugs, daily volatility reflects sensitivity to clinical trial data. This metric is an important element in assessing risks in this innovative field.
Daily change in the price of a set of shares in a market segment - Narco food
Incannex Healthcare Ltd is a biotech company. This chart shows the sector's extreme volatility. Comparison with IXHL, which specializes in cannabinoids and psychedelics, helps to assess it as a high-risk asset.
Daily change in the price of a broad market stock, index - GURU.Markets
Incannex Healthcare is an Australian company developing cannabinoid-based medicines. It operates at the intersection of two volatile sectors: biotech and cannabis. Its shares respond to scientific and regulatory news, adding unique dynamics to the market.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Incannex Healthcare
For Incannex Healthcare, year-over-year performance is a reflection of its diversified development portfolio. Its 12-month market cap depends on progress in clinical trials of its cannabinoid- and psychedelic-based drugs for the treatment of sleep apnea, brain injury, and other conditions, making it a unique but high-risk player.
Annual dynamics of market capitalization of the market segment - Narco food
Incannex, a biotech company, develops drugs based on cannabinoids and psychedelics. Its performance is completely separate from the sector and depends on news about clinical trials and legalization. Its stock price will reflect investors' speculative belief in the potential of these innovative approaches.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Incannex, which develops cannabinoid-based drugs, lives in a world of regulatory news rather than economic cycles. Its stock price (ADR) is driven not by GDP, but by steps toward legalization and successes in clinical trials. The chart is a story of high hopes and constant disappointments in the sector.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Incannex Healthcare
Incannex Healthcare is an Australian biotech company developing cannabinoid- and psychedelic-based drugs. Its monthly performance is entirely dependent on progress in its numerous clinical programs and regulatory changes.
Monthly dynamics of market capitalization of the market segment - Narco food
Incannex Healthcare is an Australian company developing pharmaceuticals based on cannabinoids and psychedelics for the treatment of various conditions. The chart below illustrates the overall dynamics of the biotech sector, where the company operates at the intersection of science and evolving legislation.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Incannex Healthcare is an Australian company developing cannabinoid- and psychedelic-based medications. This is a high-risk sector. Share price performance is entirely dependent on clinical trial results and regulatory changes, and has no correlation to overall market trends.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Incannex Healthcare
Shares of Incannex, an Australian company developing cannabinoid- and psychedelic-based medications, have been experiencing high volatility on a weekly basis. News about clinical trials and changes in drug legislation have been driving sharp fluctuations.
Weekly dynamics of market capitalization of the market segment - Narco food
Incannex shares, like those of the entire nascent medical marijuana sector, are moving on the back of a broader news cycle and expectations. Regulatory shifts and key research results are creating extreme volatility for everyone. The chart will reveal whether the company is leading the hype.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Incannex shares, like those of the entire nascent medical marijuana sector, are moving on the back of a broader news cycle and expectations. Regulatory shifts and key research results are creating extreme volatility for everyone. The chart will reveal whether the company is leading the hype.
Market capitalization of the company, segment and market as a whole
IXHL - Market capitalization of the company Incannex Healthcare
The Incannex market capitalization chart represents the financial valuation of an Australian biotech company developing cannabinoid- and psychedelic-based drugs. It reflects investor expectations for this cutting-edge, yet high-risk, sector. Its speculative dynamics tell the story of how the market evaluates the company's potential to treat various diseases.
IXHL - Share of the company's market capitalization Incannex Healthcare within the market segment - Narco food
Incannex Healthcare is an Australian biopharmaceutical company developing cannabinoid- and psychedelic-based treatments for a variety of conditions. Its market share reflects its pioneering status in this emerging field of medicine. The chart below shows the market weighting of its research.
Market capitalization of the market segment - Narco food
Incannex Healthcare is an Australian company developing pharmaceutical products based on cannabinoids and psychedelics. The chart below shows the overall market capitalization of this sector. Its dynamics reflect the hopes for the medical potential of these substances and regulatory changes around the world.
Market capitalization of all companies included in a broad market index - GURU.Markets
The biotech companies visible in the chart are researching the medicinal properties of cannabinoids and psychedelics. Incannex Healthcare, based in Australia, is conducting clinical trials of these compounds for the treatment of various conditions. Its capitalization is a risky bet on the legalization and medical use of these substances.
Book value capitalization of the company, segment and market as a whole
IXHL - Book value capitalization of the company Incannex Healthcare
Incannex is investing in the development of pharmaceuticals based on cannabinoids and psychedelics. Currently in the R&D stage, the company is using its financial assets to conduct clinical trials for the treatment of conditions such as sleep apnea and concussion.
IXHL - Share of the company's book capitalization Incannex Healthcare within the market segment - Narco food
Incannex Healthcare, an Australian biopharmaceutical company, develops cannabinoid- and psychedelic-based treatments. Its share of the sector's assets consists of R&D capacity. Its value lies in its extensive clinical pipeline.
Market segment balance sheet capitalization - Narco food
Incannex Healthcare is an Australian biopharmaceutical company. Its asset-light model focuses on R&D and clinical trials rather than manufacturing. Compared to the pharmaceutical sector, its low capital intensity is typical for research-stage companies.
Book value of all companies included in the broad market index - GURU.Markets
Incannex's assets are not plantations, but a portfolio of pharmaceutical developments based on cannabinoids and psychedelics for the treatment of sleep apnea, brain injuries, and other disorders. The company's balance sheet reflects the value of its clinical programs. The chart shows how much capital is invested in researching the medical potential of these substances.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Incannex Healthcare
Incannex Healthcare is an Australian company developing cannabinoid-based medicines. Its market capitalization is a speculative estimate of its chances of success in this emerging and highly regulated field of medicine.
Market to book capitalization ratio in a market segment - Narco food
Incannex Healthcare is an Australian company developing pharmaceuticals based on cannabinoids and psychedelics. Its valuation is a pure bet on legalization and the success of its clinical programs. This chart shows a high speculative premium to its current holdings.
Market to book capitalization ratio for the market as a whole
Incannex Healthcare is an Australian biopharmaceutical company developing cannabinoid- and psychedelic-based treatments. Its market capitalization is based on the potential of these innovative treatment approaches. The chart shows the market premium paid for research in this controversial but potentially breakthrough area of medicine.
Debts of the company, segment and market as a whole
IXHL - Company debts Incannex Healthcare
Incannex Healthcare is an Australian company developing medicinal products based on cannabinoids and psychedelics. Clinical trials in this new and highly regulated field require significant funding, and this chart shows how the company raises capital for its innovative programs.
Market segment debts - Narco food
Incannex Healthcare is an Australian biotech company developing pharmaceutical products based on cannabinoids and psychedelics. This is a cutting-edge but risky field. This chart shows how the company funds its unique clinical trials, which at this stage almost always involves equity capital.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Incannex Healthcare
Incannex Healthcare, an Australian company developing cannabinoid-based drugs, shows how dependent its research and development is on external funding. Biotech in this niche carries dual risks: scientific (the drug may not work) and regulatory (related to legalization and distribution regulations).
Market segment debt to market segment book capitalization - Narco food
Incannex Healthcare is an Australian company developing pharmaceuticals based on cannabinoids and psychedelics for the treatment of various diseases. This chart compares the debt it raised for this innovative, yet regulatory-challenging, research with the overall market capitalization of the entire sector. It illustrates the financial side of this cutting-edge field of medicine.
Debt to book value of all companies in the market
Incannex Healthcare is an Australian biotech company developing cannabinoid-based drugs. Funding clinical trials is its primary focus. The chart shows how the company manages its capital. Its debt load, compared to the biotech sector, reflects the stage of its development and the financial risks involved in reaching commercialization.
P/E of the company, segment and market as a whole
P/E - Incannex Healthcare
This chart for Incannex Healthcare, an Australian company developing cannabinoid-based drugs, is a bet on the legalization and medical use of marijuana. Investors' estimates of its potential profit are very high due to growth expectations for this emerging market. The dynamics are a reaction to clinical trial data and regulatory changes.
P/E of the market segment - Narco food
This chart reflects the average valuation for the speculative biotech sector—the benchmark for Incannex. Comparison with this metric helps investors understand how the market views the prospects of a company operating at the intersection of pharmaceuticals and medical cannabis, and what risks (regulatory and clinical) it factors into its valuation.
P/E of the market as a whole
Incannex Healthcare is an Australian biotech company developing cannabinoid- and psychedelic-based drugs for the treatment of various ailments. This is a cutting-edge but risky area of pharmaceuticals. This chart shows the market's risk appetite, allowing one to understand how regulatory changes and clinical trial results impact the valuations of companies in this speculative sector.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Incannex Healthcare
Incannex Healthcare is an Australian biopharmaceutical company developing cannabinoid- and psychedelic-based medications for the treatment of various conditions. This chart reflects analysts' highly speculative expectations regarding the future legalization and medical use of these substances, as well as the success of the company's clinical trials.
%20P%2FE%20Incannex%20Healthcare&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Incannex-Healthcare&v=1772513705080 "Chart of the company's future (projected) P/E Incannex Healthcare")
Future (projected) P/E of the market segment - Narco food
Incannex Healthcare is an Australian biopharmaceutical company developing cannabinoid- and psychedelic-based medicines for the treatment of various conditions. This chart compares its future profitability expectations with those of the pharmaceutical sector. It demonstrates how the market values its innovative, yet regulatory-challenging, research and its extensive clinical pipeline.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Narco%20food&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Narco-food&v=1772513705168 "Future (projected) P/E graph of the market segment - Narco food")
Future (projected) P/E of the market as a whole
Incannex Healthcare is an Australian pharmaceutical company developing cannabinoid-based drugs. This chart shows the company's overall risk appetite. IXHL's success depends on clinical trial results and changes in cannabis legislation. This is a story driven by science and regulation.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772513705293 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Incannex Healthcare
Incannex Healthcare is an Australian biotech company developing pharmaceuticals based on cannabinoids and psychedelics for the treatment of various diseases. This chart shows the financial trajectory of this pioneering company in this emerging field of medicine. The results reflect investments in an extensive clinical research program.
Profit of companies in the market segment - Narco food
Incannex Healthcare is an Australian biopharmaceutical company developing cannabinoid- and psychedelic-based drugs for the treatment of various conditions, such as sleep apnea and anxiety disorders. This chart shows the financial climate in the biotech sector, reflecting growing interest in the therapeutic potential of previously banned substances.
Overall market profit
Incannex Healthcare is an Australian biotech company developing cannabinoid- and psychedelic-based drugs. Its success hinges on clinical trial results and regulatory changes. It's a business that operates by its own rules and is largely unrelated to traditional economic cycles.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Incannex Healthcare
Incannex Healthcare is an Australian biotech company developing pharmaceuticals based on cannabinoids and psychedelics. This is a cutting-edge, yet legally complex, field. This chart reflects analysts' speculative expectations regarding the success of its clinical programs and regulatory changes.
%20profit%20of%20the%20company%20Incannex%20Healthcare&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Incannex-Healthcare&v=1772513705492 "Graph of future (projected) profit of the company Incannex Healthcare")
Future (predicted) profit of companies in the market segment - Narco food
Incannex Healthcare is an Australian biopharmaceutical company developing cannabinoid- and psychedelic-based medications for the treatment of various conditions. This chart shows forecasts for the innovative biotech sector. Incannex's future profitability depends on the success of its clinical programs and changes in the regulatory environment for these substances.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Narco%20food&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Narco-food&v=1772513705516 "Graph of future (predicted) profits of companies in a market segment - Narco food")
Future (predicted) profit of the market as a whole
Incannex Healthcare is an Australian company developing cannabinoid-based pharmaceuticals. Its success depends on legalization, research results, and access to capital. This earnings forecast chart reflects the overall investment climate and risk appetite, which is important for companies in such emerging and speculative industries.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772513705569 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Incannex Healthcare
Incannex Healthcare is an Australian biopharmaceutical company developing cannabinoid- and psychedelic-based drugs. This chart represents a purely speculative valuation. It reflects investor expectations for the legalization and medical use of these substances, not the company's current revenue.
P/S market segment - Narco food
Incannex Healthcare is an Australian biopharmaceutical company developing cannabinoid- and psychedelic-based drugs for the treatment of various conditions. This chart reflects the average biotech valuation, helping to understand how investors view the potential of Incannex's portfolio in these cutting-edge, yet regulatory-challenging, areas of medicine.
P/S of the market as a whole
Incannex Healthcare is an Australian biotech company developing pharmaceutical products based on cannabinoids and psychedelics. This revenue valuation indicator emphasizes that investors are not evaluating current sales, but rather the company's potential to legalize and commercialize these innovative treatments.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Incannex Healthcare
Incannex Healthcare is an Australian pharmaceutical company developing cannabinoid- and psychedelic-based medications. This chart reflects investor expectations for the future success of its clinical programs. This valuation is based on the potential revenue from its innovative drugs if approved.
%20P%2FS%20Incannex%20Healthcare&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Incannex-Healthcare&v=1772513705700 "The graph of the company's future (projected) P/S Incannex Healthcare")
Future (projected) P/S of the market segment - Narco food
Incannex Healthcare is an Australian biotech company developing cannabinoid- and psychedelic-based drugs. This chart compares the company's future revenue expectations with its industry. It reflects investor confidence in the legalization and medical potential of these substances.
%20P%2FS%20market%20segment%20graph%20-%20Narco%20food&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Narco-food&v=1772513705913 "Future (projected) P/S market segment graph - Narco food")
Future (projected) P/S of the market as a whole
Incannex Healthcare is an Australian biopharmaceutical company developing cannabinoid- and psychedelic-based medications for the treatment of various conditions. This chart reflects confidence in future growth, as Incannex operates in a new and rapidly developing field of medicine. The success of its developments could lead to the legalization and introduction of entirely new classes of drugs.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772513705971 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Incannex Healthcare
Incannex Healthcare is an Australian biopharmaceutical company developing cannabinoid- and psychedelic-based medications. Being in clinical trials, the company has no commercial sales revenue. Any revenue shown in the chart likely comes from grants or partnerships.
Sales of companies in the market segment - Narco food
Incannex Healthcare is an Australian biopharmaceutical company developing cannabinoid- and psychedelic-based medications for the treatment of various conditions. This chart illustrates the emergence and growth of a new pharmaceutical market segment, where companies like Incannex are exploring the therapeutic potential of previously banned substances.
Overall market sales
Incannex Healthcare is an Australian biopharmaceutical company developing cannabinoid-based drugs. Its operations require significant investment in R&D. The growth in total economic revenue, reflected in this chart, improves the investment climate, facilitating capital raising for clinical trials and the launch of new drugs.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Incannex Healthcare
Incannex Healthcare is an Australian biopharmaceutical company developing cannabinoid- and psychedelic-based drugs for the treatment of various conditions. This chart reflects analyst expectations for the success of clinical trials and the changing regulatory environment for these innovative therapies.
%20sales%20of%20the%20company%20Incannex%20Healthcare&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Incannex-Healthcare&v=1772513706126 "Schedule of future (projected) sales of the company Incannex Healthcare")
Future (projected) sales of companies in the market segment - Narco food
Incannex Healthcare is an Australian biopharmaceutical company developing cannabinoid- and psychedelic-based drugs for the treatment of various conditions. This chart shows forecasts for the narcotic drugs sector in medicine. It reflects the growing scientific and commercial interest in these substances as a new class of medicine.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Narco%20food&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Narco-food&v=1772513706144 "Schedule of future (projected) sales of companies in the market segment - Narco food")
Future (projected) sales of the market as a whole
Incannex Healthcare, a biopharmaceutical company developing cannabinoid-based drugs, sees this chart as an indicator of the changing regulatory environment and investment climate. Economic growth and legislative liberalization, reflected in these general trends, are creating favorable conditions for the research and commercialization of their products.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772513706163 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Incannex Healthcare
Incannex Healthcare is an Australian biopharmaceutical company conducting clinical trials of cannabinoid- and psychedelic-based drugs. This chart reflects its current status: it is in the intensive and expensive R&D phase, where the primary goal is scientific breakthroughs rather than current profits.
Market segment marginality - Narco food
Incannex Healthcare is an Australian biotech company developing cannabinoid- and psychedelic-based medications for the treatment of various conditions. Effectiveness in this emerging and highly regulated field depends on successful clinical trials and the ability to navigate regulatory requirements.
Market marginality as a whole
Incannex Healthcare is an Australian biopharmaceutical company developing cannabinoid-based medications for the treatment of various conditions. This chart shows average profitability, and Incannex operates in the growing field of medical marijuana. Their success depends on the results of clinical trials and regulatory changes.
Employees in the company, segment and market as a whole
Number of employees in the company Incannex Healthcare
Incannex Healthcare is an Australian biopharmaceutical company developing cannabinoid- and psychedelic-based treatments. This chart shows its team of scientists and clinicians. The growth in staff reflects the progress of its extensive and innovative clinical program portfolio.
Share of the company's employees Incannex Healthcare within the market segment - Narco food
Incannex Healthcare is an Australian biopharmaceutical company developing cannabinoid- and psychedelic-based medicines. This chart shows the percentage of all scientists in this cutting-edge and highly regulated field that Incannex employs. This reflects its scientific leadership and the scale of its ambitious clinical programs.
Number of employees in the market segment - Narco food
Incannex Healthcare is an Australian biopharmaceutical company developing cannabinoid- and psychedelic-based treatments. Its staff consists of scientists and clinical research specialists. This chart shows its research activity. Team growth is an indicator of progress in clinical trials.
Number of employees in the market as a whole
Incannex Healthcare is an Australian company developing cannabinoid-based medications. This sector is growing as legalization and public opinion shifts. Its dynamics are driven by regulatory decisions and research findings, rather than the overall labor market situation, as shown in this chart.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Incannex Healthcare (IXHL)
Incannex Healthcare is an R&D company working with cannabinoids. Its market capitalization is the market's valuation of its scientific developments. The very high value on this chart is typical for biotech, where intellectual property is the main asset.
%20of%20the%20company%20Incannex%20Healthcare%20(IXHL)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Incannex-Healthcare-IXHL&v=1772513706679 "Chart of market capitalization per employee (in thousands of dollars) of the company Incannex Healthcare (IXHL)")
Market capitalization per employee (in thousands of dollars) in the market segment - Narco food
Incannex Healthcare is an Australian pharmaceutical company developing cannabinoid- and psychedelic-based drugs. The company's market valuation reflects the enormous potential of these new classes of drugs. This metric demonstrates the high value investors place on each scientist working in this cutting-edge and risky field.
%20by%20market%20segment%20-%20Narco%20food&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Narco-food&v=1772513706746 "Market capitalization per employee (in thousands of dollars) by market segment - Narco food")
Market capitalization per employee (in thousands of dollars) for the overall market
Incannex Healthcare is an Australian biotech company developing cannabinoid- and psychedelic-based drugs for the treatment of various conditions. This is a cutting-edge, yet risky, field. The chart shows how the market views the potential of its portfolio of alternative medicines and the team developing them.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772513706758 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Incannex Healthcare (IXHL)
Incannex Healthcare is an Australian biotech company developing cannabinoid- and psychedelic-based drugs for the treatment of various diseases. It's an R&D company. This chart shows the burn rate of research capital per scientist in this speculative but rapidly growing field of medicine.
%20Chart%20Incannex%20Healthcare%20(IXHL)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Incannex-Healthcare-IXHL&v=1772513706814 "Company Profit Per Employee (in thousands of dollars) Chart Incannex Healthcare (IXHL)")
Profit per employee (in thousands of dollars) in the market segment - Narco food
Incannex Healthcare (IXHL) is an Australian biopharmaceutical company developing cannabinoid- and psychedelic-based drugs for the treatment of various conditions. Being in the clinical stage, the company incurs high R&D expenses. This chart does not show operating profit, but rather the efficiency with which the research team uses capital to advance its research.
%20in%20the%20market%20segment%20-%20Narco%20food&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Narco-food&v=1772513706889 "Chart of profit per employee (in thousands of dollars) in the market segment - Narco food")
Profit per employee (in thousands of dollars) for the market as a whole
Incannex Healthcare is an Australian biotech company developing cannabinoid- and psychedelic-based drugs for the treatment of various ailments. This R&D is at the cutting edge and at the riskiest. This graph shows significant losses per employee, as the company invests in expensive and time-consuming clinical trials.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772513706932 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Incannex Healthcare (IXHL)
Incannex Healthcare is an Australian biopharmaceutical company developing cannabinoid- and psychedelic-based drugs. This graph reflects future potential during clinical trials. Any revenue per employee will likely come from partnerships or grants rather than commercial sales.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Incannex-Healthcare-IXHL&v=1772513706966 "Sales chart per company employee Incannex Healthcare (IXHL)")
Sales per employee in the market segment - Narco food
Incannex Healthcare is an Australian biotech company developing pharmaceuticals based on cannabinoids and psychedelics. This chart shows the average revenue per employee in the sector. It serves as a benchmark in this nascent but speculative field, demonstrating the level of productivity required to monetize such drugs.
Sales per employee for the market as a whole
Incannex Healthcare (IXHL) is an Australian biopharmaceutical company developing cannabinoid- and psychedelic-based drugs for the treatment of various conditions (such as sleep apnea and anxiety). It is an R&D company. This chart shows the current (zero) commercial return per scientist.
Short shares by company, segment and market as a whole
Shares shorted by company Incannex Healthcare (IXHL)
Incannex Healthcare is an Australian company developing pharmaceuticals based on cannabinoids and psychedelics for the treatment of various conditions. This sector faces significant regulatory hurdles. The chart shows the number of bears betting that the company's drugs will fail FDA/TGA approval or that their commercialization will be impossible.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Incannex-Healthcare-IXHL&v=1772513707070 "Short Shares Chart for the Company Incannex Healthcare (IXHL)")
Shares shorted by market segment - Narco food
Incannex Healthcare is an Australian company developing pharmaceuticals based on cannabinoids and psychedelics. This chart measures the overall skepticism in the sector. Its rise indicates that investors are betting heavily against the entire industry, anticipating regulatory hurdles or clinical trial failures.
Shares shorted by the overall market
Incannex Healthcare develops medications based on cannabinoids and psychedelics. This is one of the most speculative and regulatory-challenged areas of biotech. This chart measures overall fear. When investors are pessimistic, they flee sectors with legal uncertainty. IXHL shares, dependent on legalization and expensive trials, are the first to be sold off.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Incannex Healthcare (IXHL)
Incannex Healthcare is an Australian biotech company developing pharmaceuticals based on cannabinoids and psychedelics. This industry is highly speculative. This oscillator measures the hype surrounding legalization and trials, showing overbought peaks (above 70) and deep oversold troughs (below 30).
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Incannex-Healthcare-IXHL&v=1772513707140 "RSI 14 indicator chart for the company's stock Incannex Healthcare (IXHL)")
RSI 14 Market Segment - Narco food
Incannex (IXHL) — "cannabis" + "psychedelics" (Australia). They're *not* "farmers," but a *biotech* that develops *medicines* based on *cannabinoids* and *psilocybin*. The "Narcofood" sector (cannabis/biotech) thrives on "hype." RSI\_14\_Seg shows the "temperature" of the *entire* industry. It helps us understand: is IXHL's growth a niche product or a result of the *general* "hype"?
RSI 14 for the overall market
Incannex Healthcare (IXHL), a cannabis biotech. This chart is an indicator of hype and risk appetite. In times of euphoria, investors are ready to "buy the dream" of legalization. In moments of panic, investors flee unprofitable, speculative industries, and the cash flow to companies burning billions is shut off.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast IXHL (Incannex Healthcare)
Incannex Healthcare is an Australian biotech company developing cannabinoid- and psychedelic-based drugs for the treatment of various conditions (such as sleep apnea and brain injury). This chart shows the analysts' average 12-month forecast, representing their collective speculative bet on the success of these R&D programs.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-IXHL-Incannex-Healthcare&v=1772513707205 "A chart showing analyst consensus forecasts for the expected stock price. IXHL (Incannex Healthcare)")
The difference between the consensus estimate and the actual stock price IXHL (Incannex Healthcare)
Incannex is an Australian biotech company conducting clinical trials of cannabinoid- and psychedelic-based drugs for the treatment of sleep apnea and anxiety. This chart measures the gap between the current share price and the consensus target price. It shows whether experts believe in this risky but cutting-edge R&D.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-IXHL-Incannex-Healthcare&v=1772513707278 "A chart showing the difference between the consensus forecast and the actual stock price. IXHL (Incannex Healthcare)")
Analyst consensus forecast for stock prices by market segment - Narco food
Incannex is an Australian biotech company working to develop cannabinoids and psychedelics into FDA-approved drugs (for sleep apnea and anxiety). This chart shows analysts' overall expectations for the entire "pharma cannabis" sector. It reflects whether experts believe these substances have a medical future.
Analysts' consensus forecast for the overall market share price
Incannex Healthcare is an Australian biotech company specializing in the development of cannabinoid- and psychedelic-based drugs for the treatment of sleep apnea, anxiety, and other conditions. This chart shows overall risk appetite. For Incannex, which operates in the speculative "addiction-medicine" sector, overall market optimism (risk appetite) is critical for funding.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Incannex Healthcare
Incannex Healthcare is an Australian next-generation biotech company. They are developing a portfolio of cannabinoid- and psychedelic-based drugs for the treatment of sleep apnea, anxiety, and other disorders. This chart is a barometer of alternative medicine, reflecting their progress in clinical trials and their ability to legalize these controversial compounds.
AKIMA Market Segment Index - Narco food
Incannex Healthcare (IXHL) is an Australian biotech company developing pharmaceuticals based on cannabinoids and psychedelics for the treatment of sleep apnea, brain injury, and other disorders. The chart shows the average index for the segment, helping investors assess how Incannex's risks and potential in this niche compare to the sector average.
The AKIM Index for the overall market
Incannex Healthcare is an Australian biotech company developing cannabinoid- and psychedelic-based medicines. This chart, which reflects the market average, provides a macro backdrop. It helps assess how this speculative scientific story in regulated areas compares to overall economic trends.
